Literature DB >> 15536613

Lewis-Sumner syndrome and multifocal motor neuropathy.

Annie Verschueren1, Jean Philippe Azulay, Shahram Attarian, José Boucraut, Jean François Pellissier, Jean Pouget.   

Abstract

We compared the clinical, electrophysiological, laboratory, and pathological features of 13 patients with Lewis-Sumner syndrome (LSS) with those of 20 patients with multifocal motor neuropathy (MMN). LSS and MMN patients have several common clinical features: age at onset, weakness in the distribution of individual peripheral nerves, mild wasting, cramps and fasciculations, partial areflexia, and frequent stepwise disease course. Cerebrospinal fluid protein level was normal or slightly elevated, but always less than 100 mg/dl. Conduction blocks are the electrophysiological hallmarks of these two neuropathies, and no differences in distribution and number of blocks were found. Contrary to MMN, lower-limb involvement at onset was frequent in LSS but extension to the upper limbs was a frequent later feature of the disease. Cranial nerve involvement was noted in 4 LSS patients during relapses and absent in all MMN patients. The major distinguishing features were the clinical and electrophysiological sensory involvement in LSS, and the lack of anti-GM1 antibodies in LSS, whereas IgM anti-GM1 were found in 40% of MMN patients. Some LSS patients responded to steroid therapy, whereas this was ineffective in MMN. From these features, LSS can be considered an entity distinct from MMN, with its own clinical, laboratory, and electrophysiological characteristics, and as an intermediate link between chronic inflammatory demyelinating polyneuropathy and MMN.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15536613     DOI: 10.1002/mus.20236

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  12 in total

Review 1.  Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies.

Authors:  Lotte Vlam; W-Ludo van der Pol; Elisabeth A Cats; Dirk C Straver; Sanneke Piepers; Hessel Franssen; Leonard H van den Berg
Journal:  Nat Rev Neurol       Date:  2011-11-22       Impact factor: 42.937

2.  Lewis-Sumner syndrome associated with infliximab therapy in ulcerative colitis.

Authors:  Giovanni Cirillo; Vincenzo Todisco; Gioacchino Tedeschi
Journal:  Neurol Sci       Date:  2016-02-02       Impact factor: 3.307

3.  A case of Lewis-Sumner syndrome showing dramatic improvement after plasma exchange.

Authors:  Young-Eun Park; Ji-Won Yook; Dae-Seong Kim
Journal:  J Korean Med Sci       Date:  2010-06-16       Impact factor: 2.153

4.  Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition?

Authors:  Emilien Delmont; Charles Benaïm; Mael Launay; Sabrina Sacconi; Marie-Hélène Soriani; Claude Desnuelle
Journal:  J Neurol       Date:  2009-07-30       Impact factor: 4.849

Review 5.  Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: treatment update.

Authors:  Andreas J Steck; Adam Czaplinski; Susanne Renaud
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

6.  Chronic inflammatory demyelinating polyneuropathy.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

Review 7.  Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants.

Authors:  Mazen M Dimachkie; Richard J Barohn; Jonathan Katz
Journal:  Neurol Clin       Date:  2013-02-16       Impact factor: 3.806

8.  A case of paraneoplastic demyelinating motor polyneuropathy.

Authors:  Sohrab Mostoufizadeh; Maryam Souri; Jérôme de Seze
Journal:  Case Rep Neurol       Date:  2012-04-25

9.  Hemiatrophy of the Tongue with Contralateral Hemiparesis in a Patient with Multifocal Acquired Demyelinating Sensory and Motor Neuropathy.

Authors:  Susumu Ikenoshita; Satoshi Yamashita; Tetsuro Sakamoto; Yohei Misumi; Yukio Ando
Journal:  J Clin Neurol       Date:  2017-08-01       Impact factor: 3.077

10.  Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Luis Querol; Ana M Siles; Roser Alba-Rovira; Agustín Jáuregui; Jérôme Devaux; Catherine Faivre-Sarrailh; Josefa Araque; Ricard Rojas-Garcia; Jordi Diaz-Manera; Elena Cortés-Vicente; Gisela Nogales-Gadea; Miquel Navas-Madroñal; Eduard Gallardo; Isabel Illa
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.